Cigarette purchases at pharmacies by patients at high risk of smoking-related illness.

Attitudes to mesalamine questionnaire: a novel tool to predict mesalamine nonadherence in patients with IBD.

Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels.

Pharmacy-based interventions to reduce primary medication nonadherence to cardiovascular medications.

Selecting a specialist: Adding evidence to the clinical practice of making referrals.

Patients' preferences in anticoagulant therapy: discrete choice experiment.

Patterns of initiation of oral anticoagulants in patients with atrial fibrillation- quality and cost implications.

Quality of care at retail clinics for 3 common conditions.

A cross-national comparison of 17 countries' insulin glargine drug labels.

Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.

Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: Cohort and nested case–control studies.

Did HEDIS get it right? Evaluating the quality of a quality measure: Adherence to β-blockers and cardiovascular outcomes after myocardial infarction.

Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.

Eliminating medication copayments reduces disparities in cardiovascular care.

Unintended consequences of a Medicaid prescription copayment policy.

Five features of value-based insurance design plans were associated with higher rates of medication adherence.

Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrel.

Despite increased use and sales of statins in India, per capita prescription rates remain far below high-income countries.

Treat or eat: Food insecurity, cost-related medication underuse, and unmet needs.

Untangling the relationship between medication adherence and post–myocardial infarction outcomes.

Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillation.

Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention.

Trends in insulin initiation and treatment intensification among patients with type 2 diabetes.

Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison.

Full prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial.

Patterns and predictors of generic narrow therapeutic index drug use among older adults.

Group-based trajectory models: A new approach to classifying and predicting long-term medication adherence.

Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study.

Time series analyses of the effect of FDA communications on use of prescription weight loss medications.

Implementing randomized effectiveness trials in large insurance systems.